Physician

Bradly Alexander Kimbrough, MD

According to 2025 Medicare claims, Bradly Kimbrough, MD (NPI: 1861998007) practices rheumatology in the Waco, TX market, with the plurality of this provider's patient population coming from Mc Lennan, TX. This provider's primary affiliated billing organization is AMERICAN ARTHRITIS & RHEUMATOLOGY ASSOCIATES-TX PLLC (NPI: 1639521859; TIN: 812174373) and primary practice location at 76710-7545. Kimbrough is affiliated with the Mayo Clinic Community ACO, LLC (ACO ID: A4617), Caravan Health ACO 43 LLC (ACO ID: A4974), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Kimbrough's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 173 traditional Medicare patients, billed 6,807 HCPCS/CPT codes, and received $119,539 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 446 prescription claims across 159 beneficiaries totaling $538,700 in drug costs, led by Orencia Clickject (Abatacept). Open Payments data shows 56 records totaling $1,398. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $986 to $119,539. Similarly, Part D prescription costs have moved sharply higher in recent years, from $577 to $538,700. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	12	16	$986
2020	46	58	$4,637
2021	29	46	$3,291
2022	28	38	$3,845
2023	N/R	N/R	N/R
2024	173	6,807	$119,539

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	12	19	$577
2019	45	151	$7,482
2020	51	251	$20,382
2021	49	245	$44,867
2022	59	242	$138,991
2023	83	288	$252,698
2024	159	446	$538,700

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	67	67	$130
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	111	135	$102
20611	Aspiration and/or injection of fluid large joint using ultrasound guidance	14	16	$85
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	92	119	$13
J1010	Injection, methylprednisolone acetate, 1 mg	22	1,695	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Orencia Clickject	Abatacept	11	308	$65,401
Actemra	Tocilizumab	14	392	$44,256
Mycophenolate Mofetil	Mycophenolate Mofetil	28	1,452	$3,014
Methotrexate	Methotrexate Sodium	98	5,821	$2,350
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	55	3,409	$1,856

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	56	$1,398	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bradly Alexander Kimbrough, MD?

Tedicare shows public-source Medicare data for Bradly Alexander Kimbrough, MD (NPI 1861998007), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bradly Alexander Kimbrough, MD have ACO affiliation data?

Bradly Alexander Kimbrough, MD is shown with ACO affiliation data for Mayo Clinic Community ACO, LLC (MSSP, ACO ID A4617), Caravan Health ACO 43 LLC (MSSP, ACO ID A4974), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Bradly Alexander Kimbrough, MD?

Bradly Alexander Kimbrough, MD is linked to AMERICAN ARTHRITIS & RHEUMATOLOGY ASSOCIATES-TX PLLC (billing NPI 1639521859) in the available physician profile data.

Does Bradly Alexander Kimbrough, MD have Open Payments data?

Bradly Alexander Kimbrough, MD has 56 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.